US2010098793A1PendingUtilityA1
Irvingia gabonensis to treat and prevent metabolic syndrome and reduce total cholesterol, ldl cholesterol, blood glucose, c-reactive protein, and leptin levels and increasing adiponectin levels
Assignee: GATEWAY HEALTH ALLIANCES INCPriority: Oct 17, 2008Filed: Oct 8, 2009Published: Apr 22, 2010
Est. expiryOct 17, 2028(~2.2 yrs left)· nominal 20-yr term from priority
Inventors:Julius Enyong Oben
A61P 3/04A61P 3/00A61K 36/185
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
In one embodiment, a method is provided for lowering C-reactive protein levels in a mammal. The method comprises administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to reduce C-reactive protein levels in the mammal. Other embodiments include, among other things, lowering leptin levels, increasing adiponectin levels, reducing body weight, decreasing LDL and total cholesterol levels, increasing fat loss, and reducing waist size in a mammal using administering a composition containing an effective amount of Irvingia gabonensis.
Claims
exact text as granted — not AI-modified1 . A method for lowering C-reactive protein levels in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to reduce C-reactive protein levels in the mammal.
2 . A method of claim 1 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 0.5 mg to 50 mg daily.
3 . A method of claim 1 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 1 mg to 10 mg daily.
4 . A method of claim 1 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 50 mg to 1000 mg daily.
5 . A method for lowering leptin levels in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to reduce leptin levels in the mammal.
6 . A method of claim 5 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 0.5 mg to 50 mg daily.
7 . A method of claim 5 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 1 mg to 10 mg daily.
8 . A method of claim 5 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 50 mg to 1000 mg daily.
9 . A method for increasing adiponectin levels in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to increase adiponectin levels in the mammal.
10 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 0.5 mg to 50 mg daily.
11 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 1 mg to 10 mg daily.
12 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 50 mg to 1000 mg daily.
13 . A method for reducing body weight in a mammal, the method comprising:
administering a composition containing an effective amount of a purified and isolated Irvingia gabonensis seed extract to a mammal to reduce weight in the mammal.
14 . A method of claim 13 , wherein the effective amount of isolated and purified Irvingia gabonensis seed extract administered is approximately 0.5 mg to 50 mg daily.
15 . A method of claim 13 , wherein the effective amount of isolated and purified Irvingia gabonensis seed extract administered is approximately 1 mg to 10 mg daily.
16 . A method of claim 13 , wherein the effective amount of isolated and purified Irvingia gabonensis seed extract administered is approximately 50 mg to 1000 mg daily.
17 . A method for decreasing LDL and total cholesterol levels in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to decrease LDL and total levels in the mammal.
18 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 0.5 mg to 50 mg daily.
19 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 1 mg to 10 mg daily.
20 . A method of claim 9 , wherein the effective amount of Irvingia gabonensis seed administered is approximately 50 mg to 1000 mg daily.
21 . A method for increasing fat loss in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal to increase fat loss in the mammal.
22 . A method for reducing waist size in a mammal, the method comprising:
administering a composition containing an effective amount of Irvingia gabonensis seed to a mammal reduce weight size in the mammal.Join the waitlist — get patent alerts
Track US2010098793A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.